QIAGEN launches QIAsymphony Connect and showcases new precision oncology advances at AMP 2025

Innate Pharma cleared by FDA to launch TELLOMAK 3 Phase 3 trial of lacutamab in CTCL

AN2 Therapeutics partners with GSK to develop boron-based TB therapies; Secures Gates Foundation funding

Exact Sciences secures US exclusive license to Freenome's blood-based colorectal cancer tests

Akeso reveals preclinical research data for novel antagonistic monoclonal antibody aimed at IL-1RAP (AK135)

Boehringer Ingelheim receives Commissioner's National Priority Voucher for HERNEXEOS (zongertinib tablets)

Evinova China and Harbour BioMed form AI partnership to accelerate biologics development

OncoHost receives Proteomics Innovation of the Year in BioTech Breakthrough Awards

Johnson & Johnson's DARZALEX FASPRO receives US FDA approval

HanchorBio to present HCB301 preclinical data at Society for Immunotherapy of Cancer's 40th Annual Meeting

Lunai Bioworks publishes breakthrough on second-generation allogeneic dendritic cell therapy in vaccines

Cizzle Biotechnology signs Letter of Intent with UK diagnostic provider

CelLBxHealth demonstrates Parsortix compatibility with Roche Tissue Diagnostics workflow at World ADC Conference

HUTCHMED completes enrollment of global Phase III SAFFRON trial for ORPATHYS and TAGRISSO combination in lung cancer

iLeukon reports FDA clearance of IND application for phase II study of ILKN421H in advanced NSCLC